-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shijiazhuang No.4 Pharmaceutical Granted Three More Utility Model Patents
Category:
Time：2020-02-28
Recently, good news came from the National Intellectual Property Administration: three research achievements independently developed by Shijiazhuang Fourth Pharmaceutical—“A Double-Layer Sterile Vertical Bag Infusion Packaging,” “A Double-Layer Sterile Soft Bag Infusion Sterilization and Temperature-Controlled Device,” and “A Double-Layer Sterile Dual-Chamber Soft Bag Infusion Packaging”—have been authorized by the National Intellectual Property Administration and have received notices of grant for utility model patents.
Recently, good news came from the National Intellectual Property Administration: three research achievements independently developed by Shijiazhuang Sihua Pharmaceutical—“A Double-Layer Sterile Vertical Bag Infusion Packaging,” “A Double-Layer Sterile Soft Bag Infusion Sterilization and Temperature-Controlled Device,” and “A Double-Layer Sterile Dual-Chamber Soft Bag Infusion Packaging”—have been granted patents by the National Intellectual Property Administration and have received notices of authorization for utility model patents.
According to the R&D team, the utility model patent “A Double-Layer Sterile Dual-Chamber Soft Bag Infusion Packaging” provides a double-layer sterile dual-chamber soft bag infusion packaging. The inner bag consists of two independent chambers, each filled separately with medicinal solutions under sterile conditions. Before clinical use, medical personnel only need to tear open the virtual weld between the two chambers, and within seconds, the process of mixing the medicinal solutions is completed, thereby avoiding contamination and addressing the storage challenges associated with multi-component products that cannot remain uniformly mixed over long periods. The two additional utility model patents—“A Double-Layer Sterile Upright Bag Infusion Packaging” and “A Double-Layer Sterile Soft Bag Infusion Sterilization Temperature-Control Device”—effectively solve the problems of inaccurate temperature measurement and unsatisfactory sterilization performance commonly found in conventional double-layer infusion packaging. These innovations provide healthcare professionals and patients with more reliable and safer products, boasting broad application prospects and significant economic benefits.
The quantity and quality of intellectual property rights have become important indicators for measuring a company’s technological innovation capability and overall strength. Continuous innovation has propelled the rapid development of Shijiazhuang Fourth Pharmaceutical, making its innovation capacity one of the key driving forces behind the company’s growth. In recent years, Shijiazhuang Fourth Pharmaceutical has steadily increased its investment in technological research and development. Relying on the technical expertise provided by the Academician Workstation, the Postdoctoral Research Workstation, and collaborative research institutes with major universities, the company actively encourages employees to break free from conventional thinking, dare to innovate, and continually enhance the company’s scientific and technological prowess. As a result, numerous scientific and technological achievements have emerged. To date, the company has been granted a total of 77 patents, including 45 invention patents and 27 utility model patents.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license